Professor
Max Rady College of Medicine
Pharmacology and Therapeutics
A205-753 McDermot Avenue
University of Manitoba
Winnipeg, Manitoba R3E 0T6
Michael Jackson, PhD
Research summary
Dr. Michael Jackson's research focuses on understanding the role of Ca2+-permeable channels in Ca2+ dysregulation, inflammation, and impaired synaptic transmission and plasticity in models of stroke and Alzheimer's disease.
His work has shown that channels such as TRPM2 and pannexin are functionally linked to the NMDA glutamate receptor, and that these channels play a role in both physiological and pathological processes.
The primary goal of his research is to gain insight into how these channels are regulated by intracellular signaling pathways, with the ultimate aim of identifying molecular targets for the development of effective treatments for neurodegenerative disorders.
Research affiliations
Principal investigator, PrairieNeuro Research Centre, Kleysen Institute for Advanced Medicine, Health Sciences Centre
Biography
Dr. Michael Jackson is an accomplished scientist and academic who is currently a professor in pharmacology and therapeutics at the University of Manitoba. He is the principal investigator of the PrairieNeuro Research Centre at the Kleysen Institute for Advanced Medicine (KIAM) and his laboratory is located in the PrairieNeuro research laboratories in KIAM.
Dr. Jackson received his PhD in pharmacology and therapeutics from McGill University in 1998. Following his graduation, he completed postdoctoral training in physiology at the University of Toronto. He then moved to the Robarts Research Institute at Western University in 2008, where he worked as a research scientist and assistant professor of physiology and pharmacology.
Throughout his career, Dr. Jackson has made significant contributions to the field of neuroscience, with a specific focus on understanding the role of Ca2+-permeable channels in Ca2+ dysregulation, inflammation, and impaired synaptic transmission and plasticity in models of stroke and Alzheimer's disease. He has published several research papers in reputable journals and has gained an international reputation as an expert in his field.
Education
- PhD (pharmacology and therapeutics), McGill University (1998)
- Postdoctoral fellow (physiology), University of Toronto (2008)
Contact us
Pharmacology and Therapeutics
Max Rady College of Medicine
A205 Chown Bldg., 753 McDermot Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0T6 Canada
204-789-3553